Neuberger Berman Emerging Markets Equity Fund R3 Class
NEMRX
NASDAQ
| Weiss Ratings | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Company Info | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Neuberger Berman | |||
| Manager/Tenure (Years) | Conrad A. Saldanha (16) | |||
| Website | http://https://www.nb.com | |||
| Fund Information | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Neuberger Berman Emerging Markets Equity Fund R3 Class | |||
| Category | Diversified Emerging Mkts | |||
| Sub-Category | Global Emerging Markets Equity | |||
| Prospectus Objective | Diversified Emerging Markets | |||
| Inception Date | Jun 21, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.77% | |||
| Asset Allocation | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.80% | |||
| Stock | 97.03% | |||
| U.S. Stock | 1.83% | |||
| Non-U.S. Stock | 95.20% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 1.72% | |||
| Convertible | 0.00% | |||
| Other Net | 0.45% | |||
| Price History | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.51% | |||
| 30-Day Total Return | 8.34% | |||
| 60-Day Total Return | 12.68% | |||
| 90-Day Total Return | 11.80% | |||
| Year to Date Total Return | 31.44% | |||
| 1-Year Total Return | 22.27% | |||
| 2-Year Total Return | 55.98% | |||
| 3-Year Total Return | 64.43% | |||
| 5-Year Total Return | 30.23% | |||
| Price | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $25.58 | |||
| 1-Month Low NAV | $23.67 | |||
| 1-Month High NAV | $25.58 | |||
| 52-Week Low NAV | $18.11 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $25.58 | |||
| 52-Week High Price (Date) | Oct 01, 2025 | |||
| Beta / Standard Deviation | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.93 | |||
| Standard Deviation | 14.94 | |||
| Balance Sheet | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 222.59M | |||
| Operating Ratios | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.95% | |||
| Turnover Ratio | 111.00% | |||
| Performance | NEMRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.52% | |||
| Last Bear Market Total Return | -9.58% | |||